Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EBIT Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 35.59-4.679.11-34.6021.34

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is 35.59 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202635.59
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2026 35.59
Positive
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,104.1 Cr -0.9% 0.3% 43.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.9%

0.3%

43.3%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses